| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |